Long-term pegylated interferon-alpha and its potential in the treatment of melanoma.
Conventional interferons including interferon-alpha (IFN-alpha) are cytokines used for years in the treatment of solid tumors and hematological malignancies. Their half-life is short. Pegylated forms of IFN-alpha present an improved pharmacokinetic profile that rendered them the preferred IFNs in hepatitis therapy. In the last decade, pegylated interferons (PegIFNs) have been investigated in melanoma patients. We review the scientific published literature on biology, pharmacokinetics, side effects and clinical applications of PegIFN-alpha in the treatment of stage III and IV melanoma. In the adjuvant setting, PegIFNalpha-2b has significant prolonged distant metastases free survival in patients with microscopic nodal involvement (stage TxN1aM0) and therefore is a promising treatment option in this patient population. In the palliative setting, monotherapy with PegIFNalpha-2alpha can induce complete remissions in a minority of stage IV melanoma patients. The combination of monochemotherapy is feasible and may result in lasting complete remissions. Ongoing research must focus on the identification of patients who mostly benefit, so that unnecessary toxicity would be avoided. Combining PegIFNs and chemotherapy or targeted agents deserves further exploration.
Dummer
Reinhard
R
Department of Dermatology, University Hospital, Zürich, Switzerland. reinhard.dummer@usz.ch
Mangana
Joanna
J
Mol Cell Biol. 1989 Nov;9(11):5062-72
2481229
Clin Cancer Res. 2007 Apr 15;13(8):2422-8
17438101
Curr Opin Oncol. 2003 Nov;15(6):431-9
14624225
Cytokine Growth Factor Rev. 1996 Aug;7(2):143-51
8899292
Nat Rev Immunol. 2008 Jul;8(7):559-68
18575461
N Engl J Med. 2006 Feb 16;354(7):709-18
16481638
Annu Rev Biochem. 1998;67:227-64
9759489
J Biol Chem. 2004 Jan 9;279(2):970-9
14578350
Proc Natl Acad Sci U S A. 1998 Jun 23;95(13):7556-61
9636188
Nature. 1980 Jul 10;286(5769):110
6157097
Cytokine Growth Factor Rev. 2002 Aug-Oct;13(4-5):413-21
12220554
J Interferon Res. 1992 Aug;12(4):237-40
1385551
J Clin Invest. 2008 Mar;118(3):1165-75
18259609
J Exp Med. 1999 Nov 15;190(10):1417-26
10562317
Blood. 1999 Mar 15;93(6):1980-91
10068671
Science. 1992 Aug 7;257(5071):809-13
1496401
Drugs. 2000 Mar;59(3):401-10
10776827
J Biol Chem. 2001 Oct 26;276(43):39765-71
11514542
J Virol. 2005 Jan;79(1):17-27
15596797
Biopolymers. 2000;55(4):254-87
11169919
Neurology. 2002 Jan 22;58(2):169-78
11805241
J Biol Chem. 2004 Jun 18;279(25):26789-96
15087447
Science. 1997 Sep 12;277(5332):1630-5
9287210
Nat Immunol. 2005 Jul;6(7):722-9
15951814
Nat Immunol. 2004 Dec;5(12):1219-26
15549123
Clin Microbiol Rev. 2001 Oct;14(4):778-809, table of contents
11585785
J Clin Oncol. 1996 Jan;14(1):7-17
8558223
Virology. 1991 Jul;183(1):419-22
1711259
J Biol Chem. 2000 Jan 28;275(4):2693-7
10644731
J Biol Chem. 1995 Jul 7;270(27):15938-41
7608146
Proc Natl Acad Sci U S A. 1992 Aug 15;89(16):7840-3
1502204
Immunol Rev. 2004 Dec;202:8-32
15546383
World J Gastroenterol. 2005 Sep 14;11(34):5401-3
16149157
Semin Liver Dis. 2003;23 Suppl 1:23-8
12934165
Annu Rev Biochem. 1987;56:727-77
2441659
Philos Trans R Soc Lond B Biol Sci. 1982 Sep 24;299(1094):7-28
6128751
EMBO J. 1999 Oct 15;18(20):5601-8
10523304
Cancer. 1987 Feb 1;59(3 Suppl):647-51
10822464
Hepatology. 2001 Aug;34(2):395-403
11481625
J Virol. 1990 Mar;64(3):1171-81
2154602
Nat Immunol. 2000 Dec;1(6):475-82
11101868
Anticancer Drugs. 2007 Nov;18(10):1221-6
17893524
Am J Reprod Immunol. 1997 Jun;37(6):412-20
9228295
Cancer. 2001 Sep 15;92(6 Suppl):1664-8
11598884
Mol Cell Biol. 1983 May;3(5):780-6
6865941
Nat Immunol. 2004 Oct;5(10):987-95
15454922
J Clin Oncol. 1987 Jul;5(7):1083-9
3598612
Science. 1999 Jun 11;284(5421):1835-7
10364556
Cancer. 2008 Sep 15;113(6):1404-11
18615619
J Immunol. 1987 Feb 1;138(3):765-74
3100615
Cancer Sci. 2008 Aug;99(8):1650-5
18754879
Lancet. 2008 Jul 12;372(9633):117-126
18620949
Nature. 1980 Feb 14;283(5748):660-2
7354853
J Interferon Cytokine Res. 2004 Dec;24(12):687-98
15684736
J Biol Chem. 1999 Oct 15;274(42):30127-31
10514501
J Exp Med. 1986 Jul 1;164(1):180-95
3014033
J Biol Chem. 1992 Mar 15;267(8):5017-20
1371992
Hepatology. 2000 Sep;32(3):647-53
10960463
Int J Immunopharmacol. 1991;13 Suppl 1:77-81
1823908
J Clin Oncol. 2000 Jan;18(1):158-66
10623706
JAMA. 1991 Sep 11;266(10):1375-83
1715409
Science. 1994 Jun 3;264(5164):1415-21
8197455
Biochemistry. 2000 Sep 5;39(35):10634-40
10978146
J Leukoc Biol. 2004 Feb;75(2):163-89
14525967
J Exp Med. 2000 Nov 6;192(9):1381-8
11067886
Mol Cell Biol. 1996 Dec;16(12):6937-44
8943349
J Virol. 2007 Jul;81(14):7776-85
17494065
J Immunol. 2015 Sep 1;195(5):1911-20
26297790
J Biol Chem. 1997 Nov 28;272(48):29991-4
9374471
Ann Oncol. 2008 Apr;19(4):801-6
18178958
Cancer. 2008 Mar 1;112(5):982-94
18236459
Trends Immunol. 2001 Oct;22(10):556-60
11574279
J Immunol. 1999 Nov 1;163(9):4647-50
10528160
Ann Oncol. 2006 Apr;17(4):563-70
16418308
Melanoma Res. 1994 Oct;4(5):327-30
7858418
Nat Med. 1999 Aug;5(8):919-23
10426316
Nat Rev Immunol. 2005 May;5(5):375-86
15864272
J Virol. 1996 Jan;70(1):647-50
8523587
Annu Rev Immunol. 1997;15:749-95
9143706
Adv Immunol. 1995;60:1-35
8607368
Science. 1991 May 3;252(5006):698-702
1902591
Dermatology. 2005;210(1):39-44
15604544
J Am Acad Dermatol. 1983 Nov;9(5):689-96
6643767
J Immunol. 1995 Mar 1;154(5):2248-56
7532663
Mult Scler. 2006 Feb;12(1):47-57
16459719
PLoS Med. 2007 May;4(5):e176
17488182
Clin Cancer Res. 2004 Mar 1;10(5):1670-7
15014018
Blood. 2002 Oct 15;100(8):2926-31
12351404
J Clin Oncol. 2001 Aug 15;19(16):3635-48
11504745
Semin Oncol. 1998 Feb;25(1 Suppl 1):9-13
9482535
J Invest Dermatol. 1990 Dec;95(6 Suppl):238S-241S
1701809
Traffic. 2002 Oct;3(10):710-7
12230469
Semin Oncol. 1997 Jun;24(3 Suppl 9):S9-4-S9-17
9208870
J Pathol. 2003 Jun;200(2):255-68
12754747
Annu Rev Immunol. 1997;15:563-91
9143700
Proc Natl Acad Sci U S A. 1994 Feb 15;91(4):1198-205
8108387
J Clin Oncol. 2000 Jun;18(12):2444-58
10856105
Nat Immunol. 2003 Jan;4(1):69-77
12483210
Science. 1992 Dec 11;258(5089):1808-12
1281555
Lancet. 2005 Oct 1;366(9492):1189-96
16198768
Int J Oncol. 2006 Jun;28(6):1385-92
16685440
Melanoma Res. 1998 Apr;8(2):149-55
9610868
Eur J Biochem. 1998 Jun 15;254(3):514-9
9688261
Melanoma Res. 2000 Feb;10(1):55-65
10711641
J Clin Oncol. 2005 Dec 10;23(35):9001-7
16260697
Cancer. 2006 Jun 1;106(11):2445-51
16639739
Science. 2002 May 31;296(5573):1653-5
12040185
Placenta. 1999 May;20(4):259-64
10329345
J Clin Oncol. 2006 Mar 1;24(7):1188-94
16505439